Key result
Only 55.88% (19 of 34) of surveyed government-owned tertiary hospitals in Nigeria had a functional cardiac marker testing facility, indicating barely adequate testing capacity.
Why the study?
Tertiary hospitals are expected to be optimally equipped for cardiac marker testing in suspected ACS, but their actual testing capacity in Nigeria was undetermined.
Cross-Sectional (n=34)
Yes
Cardiac marker testing capacity in Nigerian tertiary hospitals is barely adequate, with only 55.9% having functional facilities and prolonged turnaround times, highlighting a critical gap in acute coronary syndrome management.
May compromise timely ACS diagnosis in Nigeria; leaves open effects on outcomes and need for capacity-building studies.
Background: Cardiovascular diseases are major contributors to morbidity and mortality. It is generally recognized that cardiac markers are of particular benefit in the evaluation of patients with suspected Acute Coronary Syndrome (ACS). Tertiary hospitals, mainly teaching hospitals, are expected to be optimally equipped to offer these services. The study therefore aimed at determining the central laboratory and point-of-care cardiac marker testing capacity of tertiary hospitals in Nigeria. Method: A cross-sectional survey was carried out in government-owned tertiary hospitals in Nigeria. Data were collected using semi-structured self-administered questionnaires, and analyzed using Stata version 13 (Stata Corp., USA). Results: A total of 34 hospitals participated in the study. The mean (SD) age of respondents was 43.68 (5.2) years. A total of 19 (55.88%) hospitals were found to have a functional cardiac marker testing facility, either in the form of point-of-care, central laboratory testing or both. Of those without a facility, lack of funds to procure equipment was the major reason given. In hospitals with a testing facility, most testing devices were located in the Central laboratory. Conclusion: Cardiac marker testing capacity of tertiary hospitals in Nigeria, both in the form of point-of-care and central laboratory testing, was found to be barely adequate. Improvement is needed in this area for better diagnosis and evaluation of patients who need the tests.
No takes yet. Share an insight, caveat, or question.
Meka et al. (2022) conducted a cross-sectional in Acute Coronary Syndrome (testing capacity) (n=34). Cardiac marker testing facility availability was evaluated on Proportion of hospitals with a functional cardiac marker testing facility. Only 55.88% (19 of 34) of surveyed government-owned tertiary hospitals in Nigeria had a functional cardiac marker testing facility, indicating barely adequate testing capacity.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: